NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.19
+0.01 (0.11%)
Nov 20, 2024, 4:00 PM EST - Market closed

NeuroPace Revenue

NeuroPace had revenue of $21.06M in the quarter ending September 30, 2024, with 28.20% growth. This brings the company's revenue in the last twelve months to $76.45M, up 27.00% year-over-year. In the year 2023, NeuroPace had annual revenue of $65.42M with 43.72% growth.

Revenue (ttm)
$76.45M
Revenue Growth
+27.00%
P/S Ratio
3.41
Revenue / Employee
$447,088
Employees
171
Market Cap
274.30M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 202041.14M4.17M11.27%
Dec 31, 201936.97M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
AngioDynamics 292.73M
Poseida Therapeutics 150.86M
Lifecore Biomedical 128.44M
Mersana Therapeutics 34.84M
Eton Pharmaceuticals 34.68M
Artiva Biotherapeutics 2.60M
Revenue Rankings